C
Caplin Point Laboratories Ltd
Pharmaceuticals
SMALLCAP
Pharmaceuticals
Live Performance vs
This is a tool to communicate factual return information and should not be seen as an advertisement or promotion
| Key Metrics | This Stock | Category (Avg) |
| PE Ratio | 32.63 | 49.39 |
| PB Ratio | 6.36 | 6.29 |
| Dividend Yield | 0.25% | 0.54% |
Understand what these metrics mean.
Peer Stocks
For peer comparison & financials,
About the company
C
Caplin Point Laboratories Ltd
Caplin Point Laboratories Limited is a pharmaceutical company. The Company's product segments include Antibiotics, Non-steroidal anti-inflammatory drugs (NSAIDS), Ophthalmics, Pain Management and Anti-ulcers.
Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions